Ester Neurosciences Overview

  • Founded
  • 1997
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $15M
Latest Deal Amount

Ester Neurosciences General Information


Developer of therapeutic products for the treatment of neurological disorders. The company provides novel therapeutic products for the treatment of neurological disorders such as myasthenia gravis, alzheimer disease, multiple sclerosis and acute stress reactions.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Therapeutic Devices
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • Ackerstein Towers, Building B
  • 10th Floor, 11 Hamanofim Street
  • Herzlia Pituach 46725
  • Israel
+972 00-000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Ester Neurosciences Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 01-Dec-2007 $15M 0000 Completed Clinical Trials - Phase 2
1. Early Stage VC Completed
To view Ester Neurosciences’s complete valuation and funding history, request access »

Ester Neurosciences Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Medica Venture Partners Venture Capital Minority 000 0000 000000 0
To view Ester Neurosciences’s complete investors history, request access »